In a story published March 4, 2026, about a petition asking the Food and Drug Administration to add new warnings to antidepressants, The Associated Press erroneously reported the number of experts at a July meeting who were critics of the drugs.

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs.

Health agencies working under Robert F.